Details of the Drug

General Information of Drug (ID: DMCWT17)

Drug Name

NV-1020

Indication

Disease Entry	ICD 11	Status	REF
Liver cancer	2C12	Phase 1/2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00149396) Safety and Efficacy of a Genetically Engineered Herpes Simplex Virus NV1020 to Treat Colorectal Cancer Metastatic to Liver. U.S. National Institutes of Health.